‘Rise in cases to hit mobile shipments’

April 27, 2021 04:04 am | Updated 04:04 am IST - NEW DELHI

Smartphone shipments in India grew 23% year-on-year in the January-March quarter to over 38 million, the highest ever first-quarter shipments. However, the resurgence of COVID-19 cases in the country is likely to impact recovery of the smartphone market that has seen three successive quarters of record-breaking shipments, as per Counterpoint Research.

The growth in the first quarter of the year was driven by new product launches, promotions and financial schemes, as well as pent-up demand coming from 2020. As per the data shared by Counterpoint, China’s Xiaomi retained the top position during the Q1 with a 26% shipment share, followed by Samsung (20%), vivo (16%), realme (11%) and OPPO (11%).

“Continuing with its stellar run, India’s smartphone market registered a third consecutive quarter of record shipments in Q1 2021. But these numbers should be taken with caution as a second and more virulent wave of COVID-19 is currently on in the country and is likely to impact the coming quarters. The consumer demand will take a hit due to the ongoing COVID-19 wave and subsequent lockdowns,” said senior research analyst Prachir Singh.

Research analyst Shilpi Jain added that the Chinese brands held a 75% share in the March-ended quarter and all the major brands were focusing on new product launches to drive consumer demand. “Brands are also focusing on promotions and financial schemes to increase consumer demand,” she said.

Overall mobile handset market in the country grew 19% YoY in Q1 2021 due to the strong performance of both feature phone and smartphone segments. The feature phone market registered a 14% YoY growth during the quarter driven by strong shipments of JioPhone under its new model and subsequent promotions, it added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.